Scenic Biotech rakes in $31m Series A

Scenic Biotech BV, a developer of disease modifying therapeutics for rare genetic disorders and other devastating illnesses, has raised $31 million in Series A financing.

ByIris Dorbian

10 March 2022•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Healthcare Briefs

Scenic Biotech rakes in $31m Series A

BioMedPartners

Eir Ventures

Vesalius Biocapital

Related articles